logo

For the Inventor, By the Inventor

Berlin, Germany

Hans Wendt

This inventor holds 12 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1976-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Wendt. Retrieved from https://idiyas.com/inventor/hans-wendt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 166(Granted Patents)


Company Filing History:

goldMedal12 out of 1,409 
 
Schering Aktiengesellschaft
 patents

Years Active: 1976-1990

Loading Chart...
12 patents (USPTO):Explore Patents
1. 4918065 - Corticoid-containing preparation for topical application (1990-04-17),
2. 4701451 - Novel 6,16-dimethylcorticoids their preparation and use (1987-10-20),
3. 4645763 - 6.alpha.-methyl corticoids, their production and use (1987-02-24),
4. 4555507 - Novel 6, 16-dimethylcorticoids, their preparation and use (1985-11-26),
5. 4289763 - Novel corticoids, the preparation thereof and the use thereof (1981-09-15),
6. 4243664 - Novel corticoids (1981-01-06),
7. 4207316 - Novel 17-substituted 11 .beta.-hydroxy steroids of the pregnane series, (1980-06-10),
8. 4176126 - Novel corticoids (1979-11-27),
9. 4039668 - Corticoid-containing inhalants (1977-08-02),
10. 4011322 - Benzimidazole derivatives and process for the production thereof (1977-03-08),
11. 4008312 - Pregnane-21-oic acid derivatives (1977-02-15),
12. 3956347 - Novel pregnanoic acid derivatives (1976-05-11),

Title: The Innovative Contributions of Hans Wendt in Pharmaceutical Patents

Introduction

Hans Wendt is a prominent inventor based in Berlin, Germany, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, Wendt's work has greatly impacted topical application preparations, particularly in the realm of corticoids.

Latest Patents

Among his latest patents, two standout innovations include:

1. **Corticoid-containing preparation for topical application**: This invention outlines a pharmaceutical preparation designed for topical use, containing 0.005-2% by weight of a corticoid with anti-inflammatory activity. The formulation includes a fatty phase, an aqueous phase, an emulsifier, a preservative, and optional additional ingredients like fragrant substances or other cosmetically active components. This invention specifically focuses on the emulsion's composition, ensuring effective delivery of the corticosteroid with a particle size of the inner phase ranging from 2-50 micrometers.

2. **Novel 6,16-dimethylcorticoids their preparation and use**: This patent addresses compounds formulated for therapeutic applications, showcasing Wendt's expertise in synthesizing new chemical entities that exhibit potential medicinal benefits.

Career Highlights

Hans Wendt’s career has been marked by his iterations of innovative thought and practical application within the pharmaceutical industry. He is currently associated with Schering Aktiengesellschaft, a global leader in the pharmaceutical sector, where his research and development efforts propel advancements in drug formulation and delivery systems.

Collaborations

Collaboration has been a significant aspect of Wendt's career. He has worked alongside notable colleagues such as Henry Laurent and Rudolf Wiechert, contributing to a dynamic research environment that fosters innovation and the sharing of knowledge in drug development.

Conclusion

Hans Wendt's inventive spirit and dedication to advancing pharmaceutical applications have established him as a notable figure in the field of innovation. His patents not only reflect a commitment to enhancing drug formulations but also contribute to the broader landscape of medical treatments, focusing on improving patient care through effective medication delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…